StockData
MacroGenics Inc logo

MacroGenics Inc (MGNX) stock

MGNXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$2.05−0.12 (-5.53%)

Close on Nov 17, 2026Market cap $130.59MP/E –Yield –

MacroGenics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

MacroGenics's price to sales ratio was 0.9× on Nov 11, 2026, against 0.9× a year earlier. Over the last 5 years it ranged from 0.5× to 19.0×, with a median of 2.1×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.9×−0.0
2025Dec 31, 20250.9×−0.5
2024Dec 31, 20241.4×−3.5
2023Dec 29, 20234.9×+0.5
2022Dec 30, 20224.4×−4.0
2021Dec 31, 20218.5×−8.1
2020Dec 31, 202016.6×+6.9
2019Dec 31, 20199.7×+7.0
2018Dec 31, 20182.7×−63.9
2017Dec 29, 201766.7×+59.2
2016Dec 30, 20167.5×−3.3
2015Dec 31, 201510.8×−4.9
2014Dec 31, 201415.7×+14.6
2013Dec 31, 20131.1×–

More MacroGenics figures

See a number that looks wrong?